Emerald Green Trust trims Xos (XOS) stake below 10% with 400,000-share sale
Rhea-AI Filing Summary
Emerald Green Trust, a major shareholder of Xos, Inc., reported open-market sales totaling 400,000 shares of common stock over June 3–4, 2026. Reported sale prices ranged from about $4.52 to $6.52, with weighted average prices of $6.4602, $5.9697, $5.7794, and $5.0296 for the individual trades. Following these transactions, the trust held 1,241,269 shares of Xos common stock. A footnote states the sales were executed under a pre-arranged Rule 10b5-1 trading plan established on November 21, 2025, and that after the June 4 trades the trust ceased to be a beneficial owner of 10% or more of Xos’s outstanding common stock, so it is no longer subject to Section 16 reporting.
Positive
- None.
Negative
- None.
Insights
Large Xos holder sells 400,000 shares under a pre-set 10b5-1 plan and drops below 10% ownership while retaining a sizable stake.
The filing shows Emerald Green Trust executed four open-market sales of Xos common stock totaling 400,000 shares at prices between $4.52 and $6.52. These were all coded as “S” transactions, indicating straightforward sales rather than option exercises or other complex events.
A footnote explains the trades were carried out under a Rule 10b5-1 trading plan adopted on November 21, 2025, meaning the timing was pre-arranged. After the sales, the trust still holds 1,241,269 shares, but another footnote states it is no longer a beneficial owner of at least 10% of Xos’s common stock, so future Section 16 filings by this holder will no longer be required.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 200,000 | $5.0296 | $1.01M |
| Sale | Common Stock | 80,040 | $5.7794 | $463K |
| Sale | Common Stock | 98,800 | $5.9697 | $590K |
| Sale | Common Stock | 21,160 | $6.4602 | $137K |
Footnotes (1)
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 21, 2025. Represents weighted average sales price. The shares were sold at prices ranging from $5.445 to $6.43. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $6.45 to $6.52. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $4.52 to $5.43. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Following the reporting person's transactions on June 4, 2026, the reporting person ceased to be a beneficial owner of 10% or more of the Issuer's outstanding common stock. Accordingly, this Form 4 marks the reporting person no longer being subject to Section 16. Represents weighted average sales price. The shares were sold at prices ranging from $5.61 to $6.19. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.